Science, safety and education: Informing the psychedelic treatment of psychiatric disorders.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 633, doi. 10.1177/02698811231187928
- By:
- Publication type:
- Article
Works matching IS 02698811 AND DT 2023 AND VI 37 AND IP 7
Results: 13
1
2
Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 649, doi. 10.1177/02698811231180276
- By:
- Publication type:
- Article
3
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 707, doi. 10.1177/02698811231179910
- By:
- Publication type:
- Article
4
Psilocybin's effects on cognition and creativity: A scoping review.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 635, doi. 10.1177/02698811231179801
- By:
- Publication type:
- Article
5
Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 687, doi. 10.1177/02698811231179800
- By:
- Publication type:
- Article
6
Reply to: Marketing pitches of 'magic mushrooms' and 'psychedelics' mask that psychotomimetics use exposes those vulnerable to serious adverse effects.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
7
Marketing pitches of 'magic mushrooms' and 'psychedelics' mask that psychotomimetics use exposes those vulnerable to serious adverse effects.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 749, doi. 10.1177/02698811231169641
- By:
- Publication type:
- Article
8
A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 717, doi. 10.1177/02698811231167848
- By:
- Publication type:
- Article
9
Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 679, doi. 10.1177/02698811231164707
- By:
- Publication type:
- Article
10
Corrigendum to "Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention".
- Published in:
- 2023
- Publication type:
- Correction Notice
11
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 733, doi. 10.1177/02698811231158245
- By:
- Publication type:
- Article
12
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 660, doi. 10.1177/02698811231155117
- By:
- Publication type:
- Article
13
Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 7, p. 698, doi. 10.1177/02698811231154852
- By:
- Publication type:
- Article